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An 82-year-old man, with a large invasive mucinous adeno-carcinoma, was referred to our institution for treatment 
of refractory hypoxemia, caused by massive intrapulmonary 
shunting. At presentation, his main complaint was progres-
sive shortness of breath, which severely limited his daily 
activities. Intrapulmonary shunting was calculated using the 
100% oxygen method, which demonstrated a shunt fraction of 
20%. Serial computed tomography scanning demonstrated a 
persistent pneumonic process in the right lower lobe which, 
on transbronchial biopsy, showed a histopathologic pattern 
compatible with adenocarcinoma (Fig. 1). Because of poor 
performance status resection was not an option and emboliza-
tion of the right lower lobar artery was considered.
At pulmonary angiography, a test occlusion of the right 
lower lobar artery showed an arterial oxygen saturation increase 
from 85% to 97% within 2 minutes after occlusion (Video 1 A, B, 
Supplemental Digital Content 1 and 2, http://links.lww.com/
JTO/A366 and http://links.lww.com/JTO/A367). Because of 
these findings it was very likely that permanent occlusion of 
the right lower lobar artery would significantly reduce pulmo-
nary shunting. Embolization was performed using Amplatzer 
vascular plugs (St. Jude Medical Inc., St. Paul, MN) and 
coils (Cook Medical Inc., Bloomington, IN) (Video 1 C, D, 
Supplemental Digital Content 3 and 4, http://links.lww.com/
JTO/A368 and http://links.lww.com/JTO/A369). As expected, 
the saturation increased to 97% after total occlusion of the 
right lower lobe arteries. One month after the embolization 
the saturation still measured 95% to 96%, but more impor-
tantly, the patient had experienced a significant improvement 
in ambulation and was capable of performing normal daily 
activities again. There were no early or late complications.
DISCUSSION
Despite advancements in the treatment of lung carci-
noma, a large percentage of patients with non–small-cell lung 
carcinoma will eventually end up in a palliative setting with 
symptoms that often require palliation. Dyspnea is one of the 
symptoms of lung cancer experienced by 65% of the patients 
at some point during their illness.1 Regardless of the stage 
of lung cancer, it has a major impact on the patient’s physi-
cal, psychological, and social well-being and results in a low 
quality of life.2 Because of this, effective treatment that offers 
quick relief should be pursued.
Noninvasive therapies consist of medication (broncho-
dilators and [opioid] analgesics) and supplemental oxygen. 
However, when the airways are obstructed but pulmonary 
artery blood flow is preserved, there can be a right to left shunt, 
rendering these noninvasive therapies useless. Traditionally, 
palliative resection of the involved lobe(s) is an effective 
treatment in such cases, but carries a high risk and should be 
discouraged.3 Pulmonary artery embolization, however, is a 
noninvasive treatment, which is far better tolerated and has a 
low risk, even in patients with a poor performance status. It 
is a well-known method for treatment of pulmonary arterio-
venous malformations in patients with the Rendu Osler Weber 
syndrome and pulmonary artery aneurysms, but has not been 
investigated in patients with intrapulmonary right to left 
shunting caused by unresectable lung cancer. Complications 
of extensive pulmonary artery embolization are potentially 
serious and consist of pulmonary infarction, necrosis, and 
infection. However, the incidence of these complications in 
patients with lung carcinoma is unknown.
Our patient responded well to the pulmonary artery 
embolization and was capable of performing normal daily 
activities again up to 6 months after the embolization. After 
8 months he died of progressive disease.
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FIGURE 1.  A persistent pneumonic process in the right lower lobe compatible with adenocarcinoma on biopsy.
